Endogenous sex steroids and risk of cervical carcinoma: Results from the EPIC study

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 12, 2011, Pages 2532-2540

  Rinaldi, Sabina ^a   Plummer, Martyn ^a   Biessy, Carine ^a   Castellsagué, Xavier ^b   Overvad, Kim ^c   Kjær, Susanne Krüger ^d   Tjønneland, Anne ^d   Clavel Chapelon, Françoise ^e,f   Chabbert Buffet, Nathalie ^e,f   Mesrine, Sylvie ^e,f   Lukanova, Annekatrin ^g   Kaaks, Rudolf ^g   Weikert, Cornelia ^h   Boeing, Heiner ^h   Trichopoulou, Antonia ^i,j   Lagiou, Pagona ^i,k,l   Trichopoulos, Dimitrios ^k,l   Palli, Domenico ^m   Agnoli, Claudia ⁿ   Tumino, Rosario ^o   Vineis, Paolo ^p,q   Panico, Salvatore ^r   Bueno de Mesquita, Bas ^s,t   Van Kranen, Henk J ^s   Peeters, Petra H M ^p,t   Bakken, Kjersti ^u   Lund, Eiliv ^u   Gram, Inger Torhild ^u   Rodríguez, Laudina ^v   Xavier Bosch, F ^b   Sańchez, Maria José ^w,x   Dorronsoro, Miren ^y   Navarro, Carmen ^x,z   Gurrea, Aurelio Barricarte ^x,aa   Kjellberg, Lennart ^ab   Dillner, Joakim ^ab   Manjer, Jonas ^ac   Butt, Salma ^ac   Khaw, Kay Tee ^ad   Wareham, Nicholas ^ae   Allen, Naomi E ^af   Travis, Ruth ^af   Romieu, Isabelle ^a   Ferrari, Pietro ^a   Riboli, Elio ^p   Franceschi, Silvia ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c AARHUS UNIVERSITY   (Denmark)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e INSERM   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^j HELLENIC HEALTH FOUNDATION   (Greece)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^m CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o CIVILE M P AREZZO HOSPITAL   (Italy)

^p IMPERIAL COLLEGE LONDON   (United Kingdom)

^q HuGeF Foundation   (Italy)

^r UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^s NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^t UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^u UNIVERSITY OF TROMSØ   (Norway)

^v Health and Health Care Services Council   (Spain)

^w ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^x CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^y Basque Regional Health Department   (Spain)

^z Murcia Regional Health Authority   (Spain)

^aa INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ab UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^ac LUND UNIVERSITY HOSPITAL   (Sweden)

^ad UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ae MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^af UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; CASE-CONTROL STUDIES; ESTRADIOL; EUROPE; FEMALE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; PROGESTERONE; PROSPECTIVE STUDIES; RISK FACTORS; TESTOSTERONE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 83055198317     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0753     Document Type: Article

References (37)

1. IARC Monographs on the evaluation of carcinogenic risks to humans. Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. Vol 91. Lyon, France: IARC Press; 2008.
2. Hwang LY, Ma Y, Benningfield SM, Clayton L, Hanson EN, Jay J, et al. Factors that influence the rate of epithelial maturation in the cervix in healthy young women. J Adolesc Health 2009;44:103-10.
3. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006;119:1108-24.
4. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data on 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007;370:1609-21.
5. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118:1481-95.
6. Plummer M, Peto J, Franceschi S. Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer 2011 Aug 12. [Epub ahead of print].
7. Burger H. The menopausal transition-endocrinology. J Sex Med 2008;5:2266-73.
8. Pike MC, Pearce CL, Wu AH. Prevention of cancers of the breast, endometrium and ovary. Oncogene 2004;23:6379-91. (Pubitemid 39265506)
9. Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 2010;102:315-24.
10. Brake T, Lambert PF. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci U S A 2005;102:2490-5. (Pubitemid 40279404)
11. Chung SH, Lambert PF. Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists. Proc Natl Acad Sci U S A 2009;106:19467-72.
12. Zheng Y. [Plasma estrogen level in patients with cervical cancer]. Zhonghua Zhong Liu Za Zhi 1990;12:404-5.
13. Wang JT, Gao ES, Ding L, Cheng YY, Yan JW. [Association between endogenous hormones, hormone receptors and cervical cancer]. Zhonghua Zhong Liu Za Zhi 2006;28:494-7.
14. Shields TS, Falk RT, Herrero R, Schiffman M, Weiss NS, Bratti C, et al. A case-control study of endogenous hormones and cervical cancer. Br J Cancer 2004;90:146-52. (Pubitemid 38174954)
15. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24. (Pubitemid 36313608)
16. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65. (Pubitemid 40879595)
17. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005;12:1071-82. (Pubitemid 41815798)
18. Garcia-Closas M, Hankinson SE, Ho S, Malins DC, Polissar NL, Schaefer SN, et al. Factors critical to the design and execution of epidemiologic studies and description of an innovative technology to follow the progression from normal to cancer tissue. J Natl Cancer Inst Monogr 2000;27:147-56.
19. Bolelli G, Muti P, Micheli A, Sciajno R, Franceschetti F, Krogh V, et al. Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev 1995;4:509-13.
20. Rinaldi S, Dechaud H, Biessy C, Morin-Raverot V, Toniolo P, Zeleniuch-Jacquotte A, et al. Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2001;10:757-65. (Pubitemid 32695155)
21. Rinaldi S, Geay A, Dechaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002;11:1065-71. (Pubitemid 35192658)
22. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65 4 Suppl:1220S-8S. (Pubitemid 27152591)
23. Gelman A, Jakulin A, Pittau MG, Su YS. A weakly informative default prior distribution for logistic and other regression models. Ann Appl Stat 2008;2:1360-83.
24. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16. (Pubitemid 34498648)
25. Davison SL, Bell R. Androgen physiology. Semin Reprod Med 2006;24:71-7. (Pubitemid 43736517)
26. Lipworth L, Adami HO, Trichopoulos D, Carlstrom K, Mantzoros C. Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 1996;7:96-100. (Pubitemid 26003853)
27. Fortunati N, Catalano MG, Boccuzzi G, Frairia R. Sex hormone-binding globulin (SHBG), estradiol and breast cancer. Mol Cell Endocrinol 2010;316:86-92.
28. Elson DA, Riley RR, Lacey A, Thordarson G, Talamantes FJ, Arbeit JM. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res 2000;60:1267-75. (Pubitemid 30151994)
29. Castle PE. Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials. Int J Cancer 2011;128:997-8.
30. Chung SH, Franceschi S, Lambert PF. Estrogen and ERalpha: culprits in cervical cancer? Trends Endocrinol Metab 2010;21:504-11.
31. Lacey JV Jr, Swanson CA, Brinton LA, Altekruse SF, Barnes WA, Gravitt PE, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003;98:814-21. (Pubitemid 36959279)
32. Parazzini F, Chatenoud L, La Vecchia C, Chiaffarino F, Ricci E, Negri E. Time since last use of oral contraceptives and risk of invasive cervical cancer. Eur J Cancer 1998;34:884-8. (Pubitemid 28248501)
33. Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 2003;290:1739-48. (Pubitemid 37430624)
34. Franceschi S, Plummer M, Clifford G, de Sanjosé S, Bosch X, Herrero R, et al. Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer 2009;101:865-70.
35. Allen E, Gardner W. Cancer of the cervix of the uterus in hybrid mice following long-continued administration of estrogen. Cancer Res 1941;1:359-66.
36. Santen RJ, Boyd NF, Chlebowski RT, Cummings S, Cuzick J, Dowsett M, et al. Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer 2007;14:169-87. (Pubitemid 47242621)
37. Trimble CL, Frazer IH. Development of therapeutic HPV vaccines. Lancet Oncol 2009;10:975-80.